British Society for Antimicrobial Chemotherapy
BSAC Spring Meeting 2006 - The good, the bad and the ugly: Gram negative therapeutics in the 21st century16 March International Convention Centre, Birmingham
In the UK, we have seen a dramatic increase in the number of patients infected with ESBL-producing E.coli and Klebsiella, AmpC-producing Enterobackers and multi-resistant Acinetobacter and P.aeruginosa. Therapeutic choice is often limited, and effective treatments are at a premium.
